Registration for the September 17, 2021 "An Introduction to Treating Patients with Buprenorphine" virtual training, within a few days of your response submission you will receive a calendar invitation with a Zoom link. If you have any questions please email Ashley Bushner (asbushne@med.umich.edu)

In the past, providers were required to complete an eight-hour training to qualify for a waiver to prescribe and dispense buprenorphine for the treatment of opioid use disorder.


As of April 28th, 2021, the Department of Health and Human Services (HHS) announced that the 8-hour X-waiver buprenorphine course is no longer required to prescribe buprenorphine for the treatment of opioid use disorder for less than 30 patients. Clinicians who apply for and receive a DEA X-license may prescribe buprenorphine for OUD for up to 30 patients. Providers wishing to prescribe for more than 30 patients must complete the official DATA2000 waiver course.

"An Introduction to Treating Patients with Buprenorphine" is designed to educate providers and is not required for prescribing. Trainers Dr. Sheba Sethi and Dr. Jonathon Morrow, will cover topics such as epidemiology, stigma and harm reduction, neurobiology of addiction, buprenorphine treatment for pain, and other topics. "An Introduction to Treating Patients with Buprenorphine" is free of cost.